Synthetic surfactant protein analogues

Area of Science:

• Biochemistry
• Pulmonary Medicine
• Biomaterials Science

Background:

• Surfactant preparations for treating respiratory distress syndrome (RDS) are currently sourced from animal lungs.
• These preparations contain phospholipids and hydrophobic proteins, specifically SP-B and SP-C.
• Structural information on SP-B and SP-C allows for the design of synthetic analogues.

Purpose of the Study:

• To investigate the potential of designing synthetic analogues for SP-B and SP-C proteins used in lung surfactant formulations.
• To evaluate the efficacy of leucine-based SP-C analogues in mimicking native protein function and improving synthetic surfactant performance.

Main Methods:

• Design and synthesis of leucine-based analogues of the SP-C protein.
• Assessment of the helical folding and conformational stability of SP-C analogues.
• Evaluation of the physiological activity of synthetic surfactants containing SP-C analogues in animal models of RDS.

Main Results:

• Native SP-C analogues with a poly-Val sequence did not achieve native-like alpha-helical conformation.
• Replacement of Val with Leu in SP-C analogues resulted in efficient helical folding.
• Leu-based SP-C analogues demonstrated accelerated lipid spreading and some physiological activity in RDS animal models.
• Synthetic surfactants with SP-C analogues showed inferior in vivo activity compared to natural surfactants, possibly due to the absence of palmitoylation or SP-B.

Conclusions:

• Leucine-based analogues show promise for replacing native SP-C in synthetic surfactants, improving lipid spreading and showing some physiological activity.
• The design of SP-B analogues based solely on structural information is more challenging due to its complex dimeric structure.
• Further research is needed to fully replicate the efficacy of natural lung surfactants, potentially by incorporating SP-B or palmitoylation.